Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001558795 | SCV001780813 | likely benign | not provided | 2020-01-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002072112 | SCV002401555 | benign | Genitopatellar syndrome | 2024-10-09 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002495892 | SCV002801167 | likely benign | Genitopatellar syndrome; Blepharophimosis - intellectual disability syndrome, SBBYS type | 2022-04-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002568381 | SCV003728994 | likely benign | Inborn genetic diseases | 2022-10-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV001558795 | SCV003813951 | uncertain significance | not provided | 2019-03-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001558795 | SCV004126824 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | KAT6B: BP4, BS1 |
Prevention |
RCV004542008 | SCV004785821 | likely benign | KAT6B-related disorder | 2022-08-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |